Łukasz Kuszel (Lukasz Kuszel)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Coronavirus Disease

Systematic Review

Top Venues

International journal of molecular sciences

Journal of applied genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Wawrocka, Joanna Walczak-Sztulpa, Łukasz Kuszel, Zuzanna Niedziela-Schwartz, Anna Skorczyk-Werner, Jadwiga Bernardczyk-Meller, Maciej R Krawczynski
Coexistence of Retinitis Pigmentosa and Ataxia in Patients with PHARC, PCARP, and Oliver-McFarlane Syndromes. International journal of molecular sciences 25 (11) (2024)
Anna Wawrocka, Joanna Walczak-Sztulpa, Łukasz Kuszel, Zuzanna Niedziela-Schwartz, Anna Skorczyk-Werner, Jadwiga Bernardczyk-Meller, Maciej R Krawczynski
Coexistence of Retinitis Pigmentosa and Ataxia in Patients with PHARC, PCARP, and Oliver-McFarlane Syndromes. International journal of molecular sciences 25 (11) (2024)
Magdalena Frydrychowicz, Łukasz Kuszel, Grzegorz Dworacki, Joanna Budna
MicroRNA in lung cancer-a novel potential way for early diagnosis and therapy. Journal of applied genetics (2023)
Dagny Lorent, Rafał Nowak, Monika Jankowska, Łukasz Kuszel, Pawel Zmora
Differences in BNT126b2 and ChAdOx1 Homologous Vaccination Antibody Response among Teachers in Poznan, Poland. Vaccines 11 (1) (2023)
Dagny Lorent, Rafał Nowak, Monika Jankowska, Łukasz Kuszel, Pawel Zmora
Differences in BNT126b2 and ChAdOx1 Homologous Vaccination Antibody Response among Teachers in Poznan, Poland. Vaccines 11 (1) (2023)
Dagny Lorent, Rafał Nowak, Monika Jankowska, Łukasz Kuszel, Pawel Zmora
Differences in BNT126b2 and ChAdOx1 Homologous Vaccination Antibody Response among Teachers in Poznan, Poland. Vaccines 11 (1) (2023)
Dagny Lorent, Rafal Nowak, Carolina Roxo, Elzbieta Lenartowicz, Aleksandra Makarewicz, Bartosz Zaremba, Szymon Pawel Nowak, Łukasz Kuszel, Jerzy Stefaniak, Ryszard Kierzek, Pawel Zmora
Prevalence of Anti-SARS-CoV-2 Antibodies in Poznań, Poland, after the First Wave of the COVID-19 Pandemic. Vaccines 9 (6) (2021)